International Journal of Cardiology Research
Cheng Zhang, Shuqian Jing. Therapeutic Antibody Approach for
Pulmonary Arterial Hypertension. International Journal of Cardiology Research 1 (2021) 15–19.
The Journal of Pharmacology and Experimental Therapeutics
Cheng Zhang, et al. Therapeutic Monoclonal Antibody Antagonizing Endothelin Receptor A for Pulmonary Arterial Hypertension. The Journal of Pharmacology and Experimental Therapeutics 370 (2019) 54–61.
June 2018 – PHA’s 2018 International PH Conference and Scientific Sessions
Getagozumab: A Therapeutic Monoclonal Antibody Targeting Endothelin Receptor A for Pulmonary Arterial Hypertension
Poster number: 1013
June 2018 – ADA 2018
A phase 1b/2a study of Glutazumab for the treatment of type 2 diabetes and obesity
Abstract number: 2298-PUB
Biochemical Pharmacology 2018
Caina Li, et al. Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R antibody fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites. Biochemical Pharmacology 150 (2018) 46-53.
December 2017 – IDF Congress 2017
A phase I study to investigate the safety, tolerability and pharmacokinetics of a biased GLP-1R antibody Glutazumab
Abstract number: AD-1719
Poster number: P-0352